| P50 | author | Martina L Jones | Q51297505 |
| | Mohamed A Alfaleh | Q59690968 |
| P2093 | author name string | Stephen M Mahler | |
| | Christopher B Howard | |
| P2860 | cites work | Assembly of combinatorial antibody libraries on phage surfaces: the gene III site | Q24562659 |
| | Cholesterol loading and ultrastable protein interactions determine the level of tumor marker required for optimal isolation of cancer cells | Q24594878 |
| | Rituximab: mechanism of action | Q24607358 |
| | Continuous cultures of fused cells secreting antibody of predefined specificity | Q26776979 |
| | Drugs derived from phage display: from candidate identification to clinical practice | Q27007101 |
| | High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries | Q27647956 |
| | Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes | Q27860838 |
| | Phage Display | Q28201864 |
| | Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis | Q28246968 |
| | Directed evolution of a G protein-coupled receptor for expression, stability, and binding selectivity | Q28295016 |
| | Production of single-stranded plasmid DNA | Q29547328 |
| | Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer | Q29547699 |
| | Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface | Q29616401 |
| | Nucleotide sequence of the filamentous bacteriophage M13 DNA genome: comparison with phage fd | Q48412390 |
| | Isolation of a Bacteriophage Specific for the F+ and Hfr Mating Types of Escherichia coli K-12 | Q50278875 |
| | High-throughput microfluidics: improved sample treatment and washing over standard wells. | Q51058375 |
| | Reproducibility: Standardize antibodies used in research. | Q52969782 |
| | Filamentous phage are released from the bacterial membrane by a two-step mechanism involving a short C-terminal fragment of pIII. | Q54091874 |
| | An optimized method for cell-based phage display panning | Q56897055 |
| | Somatostatin receptors | Q57042835 |
| | Endocytosis | Q66883082 |
| | Distribution of cytokeratin polypeptides in epithelia of the adult human urinary tract | Q69079230 |
| | Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques | Q72553950 |
| | Isolation of a recombinant antibody specific for a surface marker of the corneal endothelium by phage display | Q35931702 |
| | pH imaging. A review of pH measurement methods and applications in cancers. | Q35964389 |
| | Targeting membrane proteins for antibody discovery using phage display. | Q36020577 |
| | The physical and functional behavior of capture antibodies adsorbed on polystyrene | Q36245134 |
| | Human antibodies from transgenic animals | Q36252986 |
| | A prokaryotic membrane anchor sequence: carboxyl terminus of bacteriophage f1 gene III protein retains it in the membrane | Q36309708 |
| | Antibody-selectable filamentous fd phage vectors: affinity purification of target genes | Q36434701 |
| | Selection of phage-displayed antibodies specific for a cytoskeletal antigen by competitive elution with a monoclonal antibody | Q36676791 |
| | Development trends for monoclonal antibody cancer therapeutics. | Q36790534 |
| | Phage displayed antibodies specific for a cytoskeletal antigen. Selection by competitive elution with a monoclonal antibody. | Q36795412 |
| | A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. | Q36807094 |
| | Adsorption-induced antigenic changes and their significance in ELISA and immunological disorders | Q36847078 |
| | Yeast surface display for screening combinatorial polypeptide libraries | Q36865126 |
| | Isolation of human anti-c-erbB-2 Fabs from a lymph node-derived phage display library | Q36870405 |
| | Phage display of combinatorial antibody libraries. | Q36877877 |
| | Cell isolation and expansion using Dynabeads | Q36902886 |
| | Research and development of therapeutic mAbs: An analysis based on pipeline projects | Q37027607 |
| | Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients. | Q37139387 |
| | Microselection--affinity selecting antibodies against a single rare cell in a heterogeneous population. | Q37295707 |
| | Man-made antibodies | Q37624015 |
| | Identification of three molecular and functional subtypes in canine hemangiosarcoma through gene expression profiling and progenitor cell characterization. | Q37672882 |
| | The therapeutic monoclonal antibody market | Q38296275 |
| | The current status and prospects of antibody engineering for therapeutic use: focus on glycoengineering technology | Q38316404 |
| | Hormone phage: an enrichment method for variant proteins with altered binding properties | Q38342633 |
| | Genetically engineered antibody molecules | Q38607590 |
| | Engineering chemically modified viruses for prostate cancer cell recognition. | Q38828207 |
| | Phage display-based generation of novel internalizing antibody fragments for immunotoxin-based treatment of acute myeloid leukemia. | Q38901125 |
| | A comprehensive map of molecular drug targets. | Q39026969 |
| | Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell line. | Q40461355 |
| | Phage display used for gene cloning of human recombinant antibody against the erythrocyte surface antigen, rhesus D. | Q41346208 |
| | Phage display-derived human antibodies in clinical development and therapy | Q41416393 |
| | Human-engineered monoclonal antibodies retain full specific binding activity by preserving non-CDR complementarity-modulating residues | Q41465241 |
| | Near infrared fluorescence-based bacteriophage particles for ratiometric pH imaging | Q42142581 |
| | Will Necitumumab Be Cost-Effective? | Q42268440 |
| | Identification of an immunodominant functional domain on human CD36 antigen using human-mouse chimaeric proteins and homologue-replacement mutagenesis | Q42823830 |
| | Functional expression of eukaryotic membrane proteins in Lactococcus lactis. | Q43057811 |
| | Targeting mammalian organelles with internalizing phage (iPhage) libraries | Q43122068 |
| | Dissecting membrane protein architecture: An annotation of structural complexity | Q47814773 |
| | Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library | Q34395137 |
| | High throughput identification of monoclonal antibodies to membrane bound and secreted proteins using yeast and phage display | Q34421055 |
| | Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents | Q34556950 |
| | Analysis of cross-reactive and specific anti-carbohydrate antibodies against lipopolysaccharide from Chlamydophila psittaci | Q34678171 |
| | Therapeutic applications of monoclonal antibodies | Q34743728 |
| | Optimized selection of anti-tumor recombinant antibodies from phage libraries on intact cells | Q35044851 |
| | A putative OTU domain-containing protein 1 deubiquitinating enzyme is differentially expressed in thyroid cancer and identifies less-aggressive tumours. | Q35189765 |
| | Selection strategies for anticancer antibody discovery: searching off the beaten path | Q35589427 |
| | Advances in phage display technology for drug discovery | Q35614190 |
| | Selection of scFv Antibody Fragments Binding to Human Blood versus Lymphatic Endothelial Surface Antigens by Direct Cell Phage Display | Q35628801 |
| | Phage and Yeast Display | Q35672233 |
| | The production and application of single-chain antibody fragments. | Q35672249 |
| | A New Versatile Immobilization Tag Based on the Ultra High Affinity and Reversibility of the Calmodulin-Calmodulin Binding Peptide Interaction | Q35687367 |
| | Building better monoclonal antibody-based therapeutics. | Q35817552 |
| | Membrane protein folding and stability: physical principles | Q29620789 |
| | Identification of a human anti-CD55 single-chain Fv by subtractive panning of a phage library using tumor and nontumor cell lines. | Q30631804 |
| | Toward selection of internalizing antibodies from phage libraries | Q30650054 |
| | Selection-dominant and nonaccessible epitopes on cell-surface receptors revealed by cell-panning with a large phage antibody library | Q30658749 |
| | Selection of scFv phages on intact cells under low pH conditions leads to a significant loss of insert-free phages | Q30662427 |
| | Engineering M13 for phage display | Q30707757 |
| | Biopanning and rapid analysis of selective interactive ligands | Q30760800 |
| | Phage display of a cellulose binding domain from Clostridium thermocellum and its application as a tool for antibody engineering | Q30810617 |
| | By-passing immunization. Human antibodies from V-gene libraries displayed on phage | Q30831419 |
| | High copy display of large proteins on phage for functional selections | Q30838282 |
| | Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library | Q30882235 |
| | Selection of tumor-specific internalizing human antibodies from phage libraries | Q30914112 |
| | Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library | Q30982238 |
| | Selection of phage-displayed peptides on live adherent cells in microfluidic channels | Q31004986 |
| | Simultaneous blockade of both the epidermal growth factor receptor and the insulin-like growth factor receptor signaling pathways in cancer cells with a fully human recombinant bispecific antibody. | Q31016741 |
| | Generation and characterization of single-chain antibody fragments specific against transmembrane envelope glycoprotein gp46 of maedi-visna virus. | Q31030906 |
| | An efficient strategy for cell-based antibody library selection using an integrated vector system. | Q31091174 |
| | Development of a human light chain variable domain (V(L)) intracellular antibody specific for the amino terminus of huntingtin via yeast surface display | Q31108688 |
| | Single-chain antibodies for the conformation-specific blockade of activated platelet integrin alphaIIbbeta3 designed by subtractive selection from naive human phage libraries | Q31124015 |
| | Tailoring in vitro selection for a picomolar affinity human antibody directed against vascular endothelial growth factor receptor 2 for enhanced neutralizing activity | Q31153818 |
| | Stochastic modeling and optimization of phage display | Q32067752 |
| | Isolation of anti-T cell receptor scFv mutants by yeast surface display | Q32085171 |
| | A tumor-homing peptide with a targeting specificity related to lymphatic vessels | Q32127308 |
| | Targeting of peptides to restenotic vascular smooth muscle cells using phage display in vitro and in vivo | Q33184127 |
| | Production of a human single-chain variable fragment antibody against esophageal carcinoma | Q33205947 |
| | Construction of phage display libraries from reactive lymph nodes of breast carcinoma patients and selection for specifically binding human single chain Fv on cell lines. | Q33206937 |
| | The nature of target-unrelated peptides recovered in the screening of phage-displayed random peptide libraries with antibodies | Q33210401 |
| | Filamentous phage display in the new millennium | Q33226827 |
| | Isolation of anti-CD22 Fv with high affinity by Fv display on human cells | Q33246226 |
| | Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets | Q33246904 |
| | Selection of tumor-binding ligands in cancer patients with phage display libraries | Q33252672 |
| | Generation of activation-specific human anti-alphaMbeta2 single-chain antibodies as potential diagnostic tools and therapeutic agents | Q33266325 |
| | Isolating and engineering human antibodies using yeast surface display | Q33280948 |
| | Generation and selection of immunized Fab phage display library against human B cell lymphoma | Q33290368 |
| | Isolation of anti-MISIIR scFv molecules from a phage display library by cell sorter biopanning | Q33293104 |
| | Whole IgG surface display on mammalian cells: Application to isolation of neutralizing chicken monoclonal anti-IL-12 antibodies | Q33295087 |
| | Subtractive single-chain antibody (scFv) phage-display: tailoring phage-display for high specificity against function-specific conformations of cell membrane molecules | Q33310276 |
| | Selection of anti-cancer antibodies from combinatorial libraries by whole-cell panning and stringent subtraction with human blood cells | Q33311647 |
| | An entirely cell-based system to generate single-chain antibodies against cell surface receptors | Q33331645 |
| | Isolation of human monoclonal antibodies by mammalian cell display | Q33371477 |
| | Acoustic microfluidic chip technology to facilitate automation of phage display selection. | Q33380422 |
| | Phage display derived therapeutic antibodies | Q33392248 |
| | Making antibody fragments using phage display libraries | Q33392386 |
| | Mammalian cell display for antibody engineering | Q33413791 |
| | Selecting high-affinity binding proteins by monovalent phage display | Q33421871 |
| | Rapid isolation of intrabody candidates by using an optimized non-immune phage antibody library. | Q33444162 |
| | Phage-encoded combinatorial chemical libraries based on bicyclic peptides | Q33456683 |
| | Display and selection of scFv antibodies on HEK-293T cells | Q33474388 |
| | A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodies | Q33531008 |
| | A novel high-affinity human monoclonal antibody to mesothelin. | Q33634221 |
| | Development of a novel mammalian cell surface antibody display platform | Q33661339 |
| | Internalizing Cancer Antibodies from Phage Libraries Selected on Tumor Cells and Yeast-Displayed Tumor Antigens | Q33695432 |
| | Selection of antibodies against a single rare cell present in a heterogeneous population using phage display. | Q33859354 |
| | Filamentous bacteriophage: biology, phage display and nanotechnology applications | Q33876273 |
| | Fully human antagonistic antibodies against CCR4 potently inhibit cell signaling and chemotaxis | Q33982582 |
| | Phage antibodies: filamentous phage displaying antibody variable domains | Q34031345 |
| | Tanezumab, a recombinant humanized mAb against nerve growth factor for the treatment of acute and chronic pain | Q34097542 |
| | Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumor cells: selection of specific antibodies from single-chain Fv fusion phage libraries | Q34137101 |
| | Trends in the exploitation of novel drug targets | Q34205159 |
| | Engineering antibodies by yeast display | Q34208336 |
| | Protein selection using yeast surface display | Q34215858 |
| | Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells | Q34229735 |
| | Construction of a microphage variant of filamentous bacteriophage | Q34286463 |
| | Phage display on the base of filamentous bacteriophages: application for recombinant antibodies selection | Q34287677 |
| | Antibody phage display libraries: contributions to oncology. | Q34323991 |
| | Making antibodies by phage display technology | Q34328794 |
| | Endothelial cellular response to altered shear stress | Q34336977 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P921 | main subject | membrane protein | Q423042 |
| | phage display | Q896217 |
| P577 | publication date | 2017-08-05 | |
| P1433 | published in | Antibodies (Basel) | Q27724345 |
| P1476 | title | Strategies for Selecting Membrane Protein-Specific Antibodies using Phage Display with Cell-Based Panning | |
| P478 | volume | 6 | |